Combined vaccine composed of ABCYW135 group meningococcal vaccine and Japanese encephalitis vaccine
A meningococcal and combined vaccine technology, applied in the field of combined vaccines, can solve problems such as no specific drugs
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0023] The present invention includes but not limited to the following examples
[0024] Preparation of Group A, Group C, Group W135, Group Y meningococcal polysaccharide conjugated vaccine stocks:
[0025] Group A meningococcal polysaccharide-conjugated vaccine stock solution: working seed batches of group A meningococcus are cultured in a fermenter liquid, and the culture is terminated at the late logarithmic growth phase or the early stationary phase. Sampling is carried out to measure the concentration of bacteria liquid, check for pure bacteria, and sterilize after passing the test. Add formaldehyde solution to the harvested culture liquid to sterilize or use appropriate methods such as heating to sterilize; centrifuge the sterilized culture liquid to collect the supernatant, add ten Hexaalkyltrimethylammonium bromide, mix thoroughly to form a precipitate; add an appropriate amount of calcium chloride solution to the centrifuged precipitate to make the final concentration...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com